NCT04361461 - Use of Hydroxychloroquine Alone or Associated for Inpatients With SARS-CoV2 Virus (COVID-19) | Biotech Hunter

Timeline

Start Date

April 30, 2020

Primary Completion Date

November 4, 2020

Study Completion Date

November 4, 2020

Conditions

Coronavirus InfectionsSARS-CoV 2SARS (Severe Acute Respiratory Syndrome)Pulmonary Disease

Interventions

DRUG

Hydroxychloroquine Sulfate

400 mg orally, every 12 hours x 2 doses (loading dose) and then 400 mg, once daily, orally, for 10 days.

DRUG

Hydroxychloroquine Sulfate + Azythromycin

400 mg, orally, every 12 hours x 2 doses (loading dose) and then 400 mg, once a day, orally, for 10 days associated with azithromycin, intravenously or orally, 500 mg / day, for 1 day and then 250mg / day for another 4 days.

Trial Locations (1)

04753-001

Apsen Farmacêutica S.A., São Paulo